3min chapter

All-In with Chamath, Jason, Sacks & Friedberg cover image

E43: Innovative venture strategies, Zymergen's implosion, Square acquires Afterpay, future of fintech & more

All-In with Chamath, Jason, Sacks & Friedberg

CHAPTER

Synthetic Biology Platforms

The promise of these companies is truly to be everyone wants to bet his platform for synthetic biology. They can take cells and, in a smart way, edit the cells and get those cells to make things that humans need. And as is the case with a lot of deep teck, it turns out it's really frigand hart. But zimergen didn't have anything at the end of the project to say, here's something that works, that you're willing to pay for.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode